Traws Pharma TRAW
NASDAQ TRAW
$0.25 +0.02 (+11.04%)
As of: Nov 11, 2026 · 3:42 PM EST

Traws Pharma (TRAW) Price to Earnings (2025)

Updated

Traws Pharma's (TRAW) Price to Earnings came in at 1.70 for Q4 2025.

Analysis

Traws Pharma (TRAW) Price to Earnings (2025) Analysis & Trends

For FY2025, Traws Pharma's Price to Earnings stood at 1.49.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Traws Pharma 3.36 Mn -15.03 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 1.70
API Access

Traws Pharma Price to Earnings API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-earnings&ticker=TRAW&period=max&api_key=YOUR_API_KEY